Innovotech Inc. (TSXV:IOT) entered into an agreement to acquire 60% stake in Nou Life Sciences Inc. on August 18, 2020. The transaction is in return for completing an investment of CAD 0.1 million in development expenses in Nou Life?s patented skin treatment technology. The transaction allows Innovotech to take up to two years to evaluate the technology, which rests on the linking of alpha lipoic acid and L-carnitine. David Tam is a common director of both the Company and Nou Life. As of January 19, 2021, TSX Venture Exchange approved the transaction.

Innovotech Inc. (TSXV:IOT) completed the acquisition of 60% stake in Nou Life Sciences Inc. on August 25, 2023.